Jocelyn Weiss - Concepedia

Author

Jocelyn Weiss

The University of Sydney

Also Known As

J Weiss, J. Weiss, Jocelyn C. Weiss, Jocelyn Weiss

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Engeneic (Australia)Royal North Shore Hospital Asbestos Diseases Research Institute UNSW Sydney

About

Jocelyn Weiss is an author at The University of Sydney specializing in radiation oncology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	452
2	Cell Biology	6	6	189
3	Health Sciences	3	3	99
4	Engineering	2	2	305
5	Biomolecular Engineering	1	1	290

Jocelyn Weiss

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics Jennifer A. MacDiarmid, Nancy B. Amaro-Mugridge, Jocelyn Weiss, Cancer Cell NanoparticlesNanomedicineNanotherapeuticsEngineeringNm Particles	2007	290
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma Glen Reid, Marcella Pel, Michaela B. Kirschner, Annals of Oncology Malignant Pleural MesotheliomaNovel ApproachPathologyPleural DiseaseSmall Rna	2013	263
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma Marissa Williams, Michaela B. Kirschner, Yuen Yee Cheng, Oncotarget	2015	85
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma Anthony Glover, Jing Zhao, Anthony J. Gill, Oncotarget	2015	83
Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor Overexpression Reduces Growth of Choriocarcinoma Cells<i>in Vitro</i>and<i>in Vivo</i> David B. O’Gorman, Jocelyn Weiss, Anusha Hettiaratchi, Endocrinology	2002	80
Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. David B. O’Gorman, Michael Costello, Jocelyn Weiss, PubMed ImmunologyCell ProliferationTumor Growth RateCancer BiologyTumor Biology	1999	64
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia Philip O. Saunders, Adam Cisterne, Jocelyn Weiss, Haematologica	2010	60
Increased expression of the mannose 6‐phosphate/insulin‐like growth factor‐II receptor in breast cancer cells alters tumorigenic properties <i>in vitro</i> and <i>in vivo</i> Jason S. Lee, Jocelyn Weiss, Janet L. Martin, International Journal of Cancer Breast OncologyCancer BiologyTumor BiologyMannose 6‐Phosphate/insulin‐likeCancer Cell Biology	2003	43
Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells Carolyn D. Scott, Jocelyn Weiss Journal of Cellular Physiology	2000	33
mTOR Inhibition by Everolimus in Childhood Acute Lymphoblastic Leukemia Induces Caspase-Independent Cell Death Rana Baraz, Adam Cisterne, Philip O. Saunders, PLoS ONE MitophagyApoptosisImmunologyCell DeathCell Death Mechanisms	2014	32

Page 1